These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 7569836

  • 21. Optimizing the indication of vigabatrin in children with refractory epilepsy.
    Lortie A, Chiron C, Dumas C, Mumford JP, Dulac O.
    J Child Neurol; 1997 Jun; 12(4):253-9. PubMed ID: 9203067
    [Abstract] [Full Text] [Related]

  • 22. Effects of vigabatrin on partial seizures and cognitive function.
    Grünewald RA, Thompson PJ, Corcoran R, Corden Z, Jackson GD, Duncan JS.
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1057-63. PubMed ID: 8089668
    [Abstract] [Full Text] [Related]

  • 23. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.
    Brodie MJ, Mumford JP.
    Epilepsy Res; 1999 Apr; 34(2-3):199-205. PubMed ID: 10210035
    [Abstract] [Full Text] [Related]

  • 24. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study.
    Elger CE, Brodie MJ, Anhut H, Lee CM, Barrett JA.
    Epilepsia; 2005 Dec; 46(12):1926-36. PubMed ID: 16393158
    [Abstract] [Full Text] [Related]

  • 25. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
    Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA, Pregabalin 1008-009 Study Group.
    Neurology; 2005 Feb 08; 64(3):475-80. PubMed ID: 15699378
    [Abstract] [Full Text] [Related]

  • 26. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment.
    Lindberger M, Alenius M, Frisén L, Johannessen SI, Larsson S, Malmgren K, Tomson T.
    Epilepsia; 2000 Oct 08; 41(10):1289-95. PubMed ID: 11051124
    [Abstract] [Full Text] [Related]

  • 27. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
    Schapel G, Chadwick D.
    Seizure; 1996 Dec 08; 5(4):267-70. PubMed ID: 8952011
    [Abstract] [Full Text] [Related]

  • 28. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
    Bélanger S, Coulombe G, Carmant L.
    Epilepsia; 1998 Aug 08; 39(8):878-83. PubMed ID: 9701380
    [Abstract] [Full Text] [Related]

  • 29. Long-term efficacy and cognitive effects of vigabatrin.
    Ylinen A, Kälviäinen R, Riekkinen PJ.
    Acta Neurol Scand Suppl; 1995 Aug 08; 162():47-50. PubMed ID: 7495191
    [Abstract] [Full Text] [Related]

  • 30. A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizures.
    Beran RG, Berkovic SF, Buchanan N, Danta G, Mackenzie R, Schapel G, Sheean G, Vajda F.
    Seizure; 1996 Dec 08; 5(4):259-65. PubMed ID: 8952010
    [Abstract] [Full Text] [Related]

  • 31. Vigabatrin use in psychotic epileptic patients: report of a prospective pilot study.
    Veggiotti P, De Agostini G, Muzio C, Termine C, Baldi PL, Ferrari Ginevra O, Lanzi G.
    Acta Neurol Scand; 1999 Mar 08; 99(3):142-6. PubMed ID: 10100956
    [Abstract] [Full Text] [Related]

  • 32. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial.
    Lee BI, Yi S, Hong SB, Kim MK, Lee SA, Lee SK, Shin DJ, Kim JM, Song HK, Heo K, Lowe W, Leon T.
    Epilepsia; 2009 Mar 08; 50(3):464-74. PubMed ID: 19222545
    [Abstract] [Full Text] [Related]

  • 33. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F, Sopranzi N.
    Clin Ter; 1998 Mar 08; 149(2):131-4. PubMed ID: 9780478
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reversibility of vigabratin-induced visual-field defect.
    Versino M, Veggiotti P.
    Lancet; 1999 Aug 07; 354(9177):486. PubMed ID: 10465180
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.
    Baulac M, Cavalcanti D, Semah F, Arzimanoglou A, Portal JJ.
    Seizure; 1998 Feb 07; 7(1):55-62. PubMed ID: 9548227
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.